BPC-157 / Ac-SDKP Research Formulation

A Peptide Combination for Investigating Cellular Signaling and Tissue Remodeling

This formulation combines BPC-157 with Ac-SDKP, a four-amino-acid fragment derived from the N-terminal region of thymosin β4. Supplied in capsule format, it contains BPC-157 arginate and salcaprozate sodium (SNAC).

Ac-SDKP is distinct from full-length thymosin β4. Research findings involving either compound should be interpreted according to the specific peptide, formulation, and experimental model studied.

BPC-157 Research Profile

BPC-157 is a synthetic peptide composed of 15 amino acids. It is a research peptide studied in in-vitro and animal models.

Areas of investigation include:

• Vascular signaling: Cell and animal studies have reported effects on VEGFR2 expression and the Akt-eNOS pathway, which are involved in endothelial function and blood vessel formation. Primary study
• Cell migration and survival: Research using tendon explants and cultured rat tendon fibroblasts has examined cell migration, survival under oxidative stress, and FAK-paxillin signaling. Primary study
• Tissue remodeling: Animal studies have evaluated collagen organization and tissue structure in tendon models. Primary study

These findings describe specific experimental conditions only and make no statement about this capsule formulation.

Ac-SDKP Research Profile

Ac-SDKP—also known as goralatide—is an N-acetylated tetrapeptide studied in laboratory research on collagen signaling and hematopoietic cell-cycle regulation.

Areas of investigation include:

• Collagen signaling: Preclinical studies have examined collagen deposition and myofibroblast signaling in animal models. Primary study
• Hematopoietic regulation: Ac-SDKP has been studied in laboratory models of hematopoietic stem-cell cycle entry.

Combination Research Rationale

The individual research profiles of BPC-157 and Ac-SDKP provide a rationale for investigating how vascular signaling, cell migration, and extracellular matrix regulation interact.

Potential laboratory questions include:

• Whether combined exposure produces different cellular responses from either peptide alone.
• How the combination affects markers of angiogenesis, fibroblast activity, and collagen turnover.
• How formulation variables influence peptide stability, release, and availability in a defined experimental system.

Complementary research interests do not establish synergistic activity. Any combined effect requires direct evaluation.

Evidence and Formulation Context

The studies cited above concern individual peptides and specific experimental preparations. They do not establish the stability, oral bioavailability, safety, or efficacy of this capsule combination. The inclusion of SNAC should not be interpreted as proof of systemic peptide delivery.

Findings involving full-length thymosin β4 cannot be applied to Ac-SDKP, which is a different peptide.

Product Specifications

• Product name: BPC-157 / Ac-SDKP Research Formulation
• Listed peptide amounts: BPC-157 500 mcg; Ac-SDKP 2.5 mg
• BPC-157 form: Arginate salt
• Additional formulation component: Salcaprozate sodium (SNAC)
• Format: Capsules
• Count: 60 capsules
• SKU: BPTB-CAP-102.5MG
• Brand: Alpha Omega Peptide

Research Use Only

For laboratory research and educational reference only. Not for human consumption, therapeutic use, or use as a dietary supplement. This product is not an FDA-approved drug. Purchasers are responsible for ensuring that its acquisition, handling, and use comply with applicable laws and institutional requirements.

Related Products

• Acetic Acid .6% 10ML
• BPC-157 500MCG Capsules
• ARA-290 10MG

Browse more in Capsules.